Home
    • Plans Blog Contact
    CHEMED CORP logo

    CHEMED CORP

    CHE
    Last price US$511.04
    Market cap US$6.5b
    12M price change 10.27%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Universal Health Services IncUHS Industry peer DaVita HealthCare Partners IncDVA Industry peer Tenet HealthcareTHC Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    CHEMED CORP Overview

    Industry: Medical Care Facilities

    Sector: Healthcare

    Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for CHEMED CORP into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Apr 23, 2026

    Quarterly result summary

    Revenue was $420M (reported); EPS was $5.65 (reported).

    Revenue $420M reported
    EPS $5.65 reported
    Operating income $84.6M -11% YoY
    Net income $66.3M -8% YoY

    What changed

    • Revenue reported to $420M; EPS reported to $5.65.
    • Operating income -11% YoY to $84.6M.
    • Net income -8% YoY to $66.3M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Apr 28, 2026 SEC filing 8-K Apr 23, 2026 SEC filing FORM 10-K Feb 27, 2026 SEC filing 8-K Feb 25, 2026 Earnings release Earnings release Feb 25, 2026 SEC filing 10-Q Oct 31, 2025 SEC filing 8-K Oct 28, 2025 Earnings release Earnings release Oct 28, 2025 SEC filing 10-Q Jul 31, 2025 SEC filing FORM 8-K Jul 29, 2025 Earnings release Earnings release Jul 29, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    CHEMED CORP boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , Tenet Healthcare are companies with high ratings.

    Return on Equity

    Score 3.64/5
    CHEMED CORP stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    CHEMED CORP CHE US$6.5b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 4.74/5
    CHEMED CORP commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    CHEMED CORP CHE US$6.5b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , Tenet Healthcare are companies with high ratings.

    Leverage

    Score 2.38/5
    CHEMED CORP registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    CHEMED CORP CHE US$6.5b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    CHEMED CORP logo

    CHEMED CORP

    US$511.04

    US$401.19

    -21.5% vs price

    US$6.5b

    0.12%

    10.27%